Current options and investigational drugs for the treatment of eosinophilic esophagitis.

Sonsoles Tamarit-SebastiánFrancisco Miguel Ferrer-SolerAlfredo J Lucendo

Published in: Expert opinion on investigational drugs (2022)

Therapies under investigation potentially can target multiple Th2-associated diseases that converge in EoE patients. Therapeutic strategies require a personalized and patient-centered approach to reduce the burden of the disease, and cost-effectiveness analysis to position their use in a complex therapeutic landscape.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
single cell
risk factors
replacement therapy
drug induced
chronic rhinosinusitis